EX-10.21 14 d144462dex1021.htm EX-10.21Agreement to Assign Patent Applications • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 Jurisdiction[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
AGREEMENT TO ASSIGN PATENT APPLICATIONSAgreement to Assign Patent Applications • August 9th, 2016 • Protagonist Therapeutics, Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 9th, 2016 Company Industry JurisdictionWHEREAS, the Parties have entered into a RESEARCH COLLABORATION AND LICENSE AGREEMENT dated as of June 16, 2012 as amended by Agreement on addition of Additional Collaboration Program, dated 16th September 2013 (“Collaboration Agreement”);
AGREEMENT TO ASSIGN PATENT APPLICATIONSAgreement to Assign Patent Applications • June 22nd, 2016 • Protagonist Therapeutics, Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 22nd, 2016 Company Industry JurisdictionWHEREAS, the Parties have entered into a RESEARCH COLLABORATION AND LICENSE AGREEMENT dated as of June 16, 2012 as amended by Agreement on addition of Additional Collaboration Program, dated 16th September 2013 (“Collaboration Agreement”);